LPL Financial
NVNO

LPL Financial’s enVVeno Medical NVNO Stock Holding History

LPL Financial’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-29
Closed -$11K – 3845
2020
Q3 		$11K Buy
+29
New +$9.83K ﹤0.01% 3531

Other funds holding NVNO

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

LPL Financial's NVNO Position: Q4 2020 in Review

LPL Financial sold out of enVVeno Medical (NVNO) in Q4 2020, closing a stake of 29 shares — an estimated $11K sold.

LPL Financial first reported a position in NVNO in Q3 2020 and held it in 1 quarter. The position peaked at $11K in Q3 2020. 7 funds tracked by Wall St. Rank hold NVNO as of Q4 2020.

  • LPL Financial reported no remaining enVVeno Medical position as of Q4 2020 after selling out during the quarter.
  • LPL Financial sold 29 enVVeno Medical shares in Q4 2020, an estimated $11K.
  • LPL Financial first reported a position in enVVeno Medical in Q3 2020 and held it in 1 quarter.
  • LPL Financial's enVVeno Medical position peaked at $11K in Q3 2020.
  • 7 funds tracked by Wall St. Rank held enVVeno Medical as of Q4 2020.

Based on LPL Financial's 13F filing for Q4 2020, filed 12 Feb 2021.